NCT01620125View on ClinicalTrials.gov

Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Type 2 DiabetesInsulin Resistance
Interventions
DIETARY_SUPPLEMENT

Lactobacillus reuteri DSM 17938

Ordinary treatment against type 2 diabetes is supplemented with one tablet containing 100 million Lactobacillus reuteri DSM 17398, once daily for 12 weeks

Trial Locations (1)

S-413 45

Gothia Forum, CTC, Gröna Stråket 12, Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Vastra Gotaland Region

OTHER_GOV

NCT01620125 - Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter